Open access
Sep 2026
Exploratory serum proteomics and independent validation identify SLC3A2 as a candidate biomarker associated with the near-death state
SLC3A2 emerged as a candidate biomarker that may complement existing clinical scoring systems, although its incremental and independent prognostic value requires confirmation in larger external cohorts.
Sheng-Ling Wang, Xi-An Yan, Wei Wang et al.
· Scientific Reports · 0 citations